Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Management of nasotracheal intubation complications
IRCT2016102122951N2Phase 3Completed
- Sponsor
- Research Deputy of Tabriz University of Medical Sciences
- Start
- Mar 2016
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of mupirocin, sponsored by Research Deputy of Tabriz University of Medical Sciences. Primary endpoint: Endotracheal nasal tube bacterial load. Started Mar 2016; status: completed.
02
Drugs
mupirocin
Beyond the preview
Go deeper on IRCT2016102122951N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016102122951N2.